Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Kidney Disease
100%
Thrombotic
100%
Emerging Problems
100%
Ovarian Cancer Recurrence
100%
Angiopathy
100%
Recurrent Ovarian Cancer
60%
Consecutive Patients
40%
Ovarian Cancer
40%
Pegylated Liposomal Doxorubicin
40%
Retrospective Review
20%
Medical Center
20%
National Kidney Foundation
20%
Recurring
20%
Chemotherapy
20%
Additional Treatment
20%
Long-term Treatment
20%
Gemcitabine
20%
Renal Disease
20%
Cancer Institute
20%
Clinical Remission
20%
Advanced Stage
20%
Survival Time
20%
Thrombotic Microangiopathy
20%
Bevacizumab
20%
Taxanes
20%
Renal Biopsy
20%
Topotecan
20%
Long-term Consequences
20%
Platinum-based Chemotherapy
20%
Egfr
20%
Therapeutic Outcome
20%
Taxane-based Chemotherapy
20%
Medicine and Dentistry
Recurrent Disease
100%
Chronic Kidney Disease
100%
Vascular Disease
100%
Ovarian Cancer
100%
Recurrent Ovarian Cancer
60%
Doxorubicin
40%
Nephropathy
20%
Malignant Neoplasm
20%
Renal Biopsy
20%
Gemcitabine
20%
Survival Time
20%
Bevacizumab
20%
Topotecan
20%
Thrombotic Thrombocytopenic Purpura
20%